{
  "anxiety_disorders": {
    "comorbidity": {
      "depression": "60% comorbidity rate (NIMH)",
      "substance_use": "Alcohol use disorder in 20-25% of cases",
      "medical_conditions": ["Irritable bowel syndrome (IBS)", "Cardiovascular issues", "Chronic pain disorders"]
    },
    "cultural_considerations": {
      "symptom_presentation": {
        "Western": "Emphasis on cognitive symptoms (worry)",
        "Asian": "Higher somatic complaints (headaches, fatigue)",
        "Latino": "Nervios concept encompassing physical/emotional distress"
      },
      "treatment_barriers": ["Language barriers", "Stigma in collectivist cultures", "Religious interpretations"]
    },
    "treatment_timelines": {
      "SSRIs": "4-6 weeks for initial effect; 3 months for full therapeutic benefit",
      "CBT": "12-16 weekly sessions for measurable improvement",
      "maintenance": "6-12 month treatment recommended after symptom remission"
    }
  },
  "major_depressive_disorder": {
    "comorbidity": {
      "anxiety": "50-60% of cases (APA)",
      "chronic_conditions": ["Diabetes (2x risk)", "Cardiovascular disease", "Chronic pain (30-50%)"],
      "substance_use": "Nicotine dependence in 40% of cases"
    },
    "cultural_considerations": {
      "diagnostic_variations": {
        "African_American": "Higher rates of undiagnosed depression due to somatic focus",
        "East_Asian": "Greater emphasis on physical symptoms over mood complaints",
        "Middle_Eastern": "Spiritual explanations affecting help-seeking"
      },
      "culturally_adapted_therapies": [
        "Family-focused interventions for collectivist cultures",
        "Spiritually-integrated CBT",
        "Bilingual psychotherapy"
      ]
    },
    "treatment_timelines": {
      "acute_phase": "4-12 weeks to achieve symptom remission",
      "continuation": "4-9 months to prevent relapse",
      "maintenance": "1-3 years for recurrent/severe cases"
    }
  },
  "bipolar_disorder": {
    "comorbidity": {
      "anxiety": "75% lifetime prevalence (NIMH)",
      "substance_use": "60% develop substance use disorder",
      "medical": ["Migraines (35%)", "Metabolic syndrome", "Thyroid disorders"]
    },
    "cultural_considerations": {
      "diagnostic_challenges": {
        "BIPOC": "Higher misdiagnosis rates (often as schizophrenia)",
        "Religious_contexts": "Mania symptoms interpreted as spiritual experiences"
      },
      "treatment_approaches": [
        "Cultural formulation interviews (DSM-5)",
        "Family-inclusive psychoeducation",
        "Traditional healing integration"
      ]
    },
    "treatment_timelines": {
      "mood_stabilizers": "1-3 weeks for acute mania control",
      "depressive_episodes": "6-12 weeks for stabilization",
      "maintenance": "Lifelong treatment with periodic monitoring"
    }
  },
  "schizophrenia": {
    "comorbidity": {
      "substance_use": "50% nicotine dependence rate",
      "medical": ["Metabolic syndrome (40-50%)", "Cardiovascular disease", "Diabetes (2-3x risk)"],
      "suicide": "5-10% lifetime risk (WHO)"
    },
    "cultural_considerations": {
      "symptom_interpretation": {
        "Hallucinations": "Cultural acceptance in spiritual traditions",
        "Delusions": "Theme variations based on cultural context"
      },
      "recovery_models": [
        "Collectivist: Family-centered care",
        "Individualist: Independent living focus",
        "Indigenous: Community reintegration ceremonies"
      ]
    },
    "treatment_timelines": {
      "acute_psychosis": "4-8 weeks for antipsychotic response",
      "stabilization": "3-6 months for functional improvement",
      "long_term": "Continuous treatment with 6-month efficacy reviews"
    }
  },
  "comorbidity_patterns": {
    "anxiety-depression": {
      "prevalence": "60-70% co-occurrence (NIMH)",
      "clinical_impact": "Longer recovery time; 3x disability days",
      "treatment_approach": "SSRIs + CBT with anxiety/depression modules"
    },
    "mental-physical": {
      "diabetes_depression": "Bidirectional risk: 2x higher rates each way",
      "CVD_anxiety": "Cardiac patients with anxiety have 3x mortality risk"
    }
  },
  "cultural_competence": {
    "assessment_guidelines": [
      "Use validated cross-cultural screening tools",
      "Assess idioms of distress (e.g., susto, nervios)",
      "Evaluate spiritual/explanatory models",
      "Consider migration trauma history"
    ],
    "treatment_adaptations": {
      "pharmacotherapy": "Ethnic variations in medication metabolism",
      "psychotherapy": [
        "Cultural congruence in therapist-client matching",
        "Multilingual cognitive assessments",
        "Traditional healing collaborations"
      ]
    }
  },
  "treatment_benchmarks": {
    "medication": {
      "SSRIs": {
        "onset": "2-4 weeks for initial effects",
        "peak": "6-12 weeks for maximum benefit",
        "duration": "6-24 months maintenance"
      },
      "antipsychotics": {
        "acute": "1-4 weeks for symptom reduction",
        "maintenance": "Lifelong with quarterly monitoring"
      }
    },
    "psychotherapy": {
      "CBT": "12-20 sessions for durable change",
      "DBT": "6-12 months for skill mastery",
      "trauma_focused": "8-25 sessions for PTSD resolution"
    }
  }
}